OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
March 02, 2022
The ROSS X-Series Inline Ultra-High Shear Mixer produces quality dispersions, suspensions, and emulsions in a variety of industries.
Aizon's Asset Health Application system is customized to manage each manufacturer's unique asset maintenance needs.
Linkam Scientific’s RHGen Relative Humidity (RH) controller allows for precise control of sample humidity without need for an external dry air supply.
New England Biolabs Luna Probe One-Step RT-qPCR Mix with UDG enables sensitive, linear, real-time detection of target RNA sequences.
Reducing US dependency on overseas pharma manufacturing may prove critical in navigating supply chain disruptions.
The acquisition and analysis of MS data can be made more efficient with the integration of modern software tools.
Although the bio/pharma supply chain has vulnerabilities that still need to be addressed, the COVID-19 pandemic has left lasting effects—some of them for the better.
February 24, 2022
Eli Lilly and Company are investing $700 million into a Boston-based facility for the newly announced Institute for Genetic Medicine.
Scottish Enterprise has awarded £20 million (US$27 million) to Valneva Scotland to advance vaccine development.
February 23, 2022
Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.